+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Topical Drugs Market Size, Share & Trends Analysis Report by Type (Semi-solid, Liquid), by Route Of Administration (Dermal, Ophthalmic), by End-use (Burn Centers, Hospitals & Clinics), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • July 2022
  • Region: Global
  • Grand View Research
  • ID: 5645001
Description Jump to:
The global topical drugs market size is expected to reach USD 217.79 billion by 2030. The industry is expected to grow at a CAGR of 10.1% from 2022 to 2030. The key factors contributing to the industry growth include the increased prevalence of skin disorders coupled with strategic collaborations between key players. The increasing prevalence of skin infections, such as psoriasis, atopic dermatitis, and eczema, coupled with the rising demand for eye and ear therapies is expected to drive the demand for transdermal or dermal medicines during the forecast period. For instance, in October 2021, AbbVie Inc. received FDA approval for Vuity, a pilocarpine HCl ophthalmic solution for treating presbyopia.

In addition, according to the NCBI, the prevalence of psoriasis is nearly 1.92% and 1.5% among European and North American populations. The launch of topical medicines to treat skin diseases is also anticipated to propel the demand for dermal drugs. For instance, in September 2020, Bausch Health, Canada launched a novel antipsoriatic agent, Duobrii lotion for psoriasis patients.Advancements in technology and increased acquisitions and mergers activities among key players, such as Alcon, Inc. and Novartis AG, are anticipated to boost the industry's growth. For instance, in June 2022, Novartis AG acquired Kedalion Therapeutics, thereby acquiring AcuStream technology to facilitate accurate dermal delivery of ophthalmic medicines.

Moreover, in May 2022, Alcon Inc. acquired Eysuvis (loteprednol etabonate suspension) for topical ophthalmic use from Kala Pharmaceuticals, Inc., thereby adding to its existing portfolio of dry eye drugs.A high incidence of burn injuries is expected to render high utilization of topical medicines in treating burn injuries. For instance, according to the WHO, an estimated 11 million burn injuries occur annually worldwide, out of which about 180,000 cases are fatal. Various topical agents are used in treating burn injuries including silver sulfadiazine cream, bismuth-impregnated petroleum gauze, cerium nitrate, mafenide acetate, and nanocrystalline silver among others.

Topical Drugs Market Report Highlights

  • The semi-solid formulations segment dominated the market in 2021 owing to their high stability in atmospheric conditions and increased use of personalized drugs
  • The dermal segment dominated the industry in 2021 due to the increased utilization of transdermal patches to reduce tobacco consumption
  • The home care settings segment dominated the industry in 2021 due to the ease of administration among the geriatric population
  • North America was the largest regional market in 2021 due to strategic initiatives and collaborations among key players for the development & launch of dermal products


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.6 List of primary sources
1.4 Information or data analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using a bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.11.3 Objective 3
1.11.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.2 Market restraint analysis
3.6 PESTEL Analysis
Chapter 4 Global Topical Drugs Market - Segment Analysis, By Type, 2018-2030 (USD Million)
4.1 Global Topical Drugs Market: Type Movement Analysis
4.2 Semi-solid formulations
4.2.1 Semi-solid formulations market estimates and forecast, 2018 - 2030 (USD Million)
4.2.2 Creams
4.2.2.1 Creams market estimates and forecast, 2018 - 2030 (USD Million)
4.2.3 Ointments
4.2.3.1 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
4.2.4 Lotions
4.2.4.1 Lotions market estimates and forecast, 2018 - 2030 (USD Million)
4.2.5 Gel
4.2.5.1 gel market estimates and forecast, 2018 - 2030 (USD Million)
4.2.6 Pastes
4.2.6.1 Pastes market estimates and forecast, 2018 - 2030 (USD Million)
4.3 Liquid Formulations
4.3.1 Liquid formulations market estimates and forecast, 2018-2030 (USD Million)
4.3.2 Suspensions
4.3.2.1 Suspensions market estimates and forecast, 2018 - 2030 (USD Million)
4.3.3 Solutions
4.3.3.1 Solutions market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Solid Formulations
4.4.1 Solid formulations market estimates and forecast, 2018-2030 (USD Million)
4.4.2 Powders
4.4.2.1 Powders market estimates and forecast, 2018 - 2030 (USD Million)
4.4.3 Suppositories
4.4.3.1 Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
4.5 Transdermal Products
4.5.1 Transdermal products market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Transdermal Patches
4.5.2.1 Transdermal patches market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3 Transdermal Semi-Solids
4.5.3.1 Transdermal semi-solids market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5 Global Topical Drugs Market - Segment Analysis, by Route of Administration, 2018-2030 (USD Million)
5.1 Global Topical Drugs Market: Route of Administration Movement Analysis
5.2 Dermal Drug Delivery
5.2.1 Dermal Drug Delivery market estimates and forecast, 2018-2030 (USD million)
5.3 Ophthalmic Drug Delivery
5.3.1 Ophthalmic Drug Delivery market estimates and forecast, 2018-2030 (USD million)
5.4 Rectal Drug Delivery
5.4.1 Rectal drug delivery market estimates and forecast, 2018-2030 (USD million)
5.5 Vaginal Drug Delivery
5.5.1 Vaginal drug delivery market estimates and forecast, 2018-2030 (USD million)
5.6 Nasal Drug Delivery
5.6.1 Nasal drug delivery market estimates and forecast, 2018-2030 (USD million)
Chapter 6 Global Topical Drugs Market - Segment Analysis, By End-use, 2018-2030 (USD Million)
6.1 Global Topical Drugs Market: End-Use Movement Analysis
6.2 Home Care Settings
6.2.1 Home Care Settings market estimates and forecast, 2018-2030 (USD million)
6.3 Hospitals & Clinics
6.3.1 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD million)
6.4 Burn Centers
6.4.1 Burn Centers market estimates and forecast, 2018-2030 (USD million)
6.5 Other Facilities
6.5.1 Other facilities market estimates and forecast, 2018-2030 (USD million)
Chapter 7 Topical Drugs Market: Segment Analysis, by Region, 2018-2030 (USD Million)
7.1 Topical Drugs Market: Regional Movement Analysis
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2 Europe
7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.2 U.K.
7.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.5 Spain
7.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.6 Italy
7.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.7 Russia
7.1.2.7.1 Russia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3 Asia Pacific
7.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.3 China
7.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.4 India
7.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.5 Australia
7.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.6 South Korea
7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.7 Singapore
7.1.3.7.1 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.4 Argentina
7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5 Middle East & Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.4 United Arab Emirates
7.1.5.4.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Global Topical Drugs Market: Competitive Analysis
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Major deals & strategic alliances analysis
8.1.1.1 New Product Launches
8.1.1.2 Mergers and Acquisitions
8.1.1.3 Partnerships & Agreements
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.2.3 Emerging Players
8.2.4 Heat Map Analysis
8.3 Company Market Position Analysis
8.4 Vendor Landscape
8.4.1 List of Key Distributors and Channel Partners
8.4.2 List of Potential End Users
8.4.3 Key Company Market Share Analysis, 2021
8.5 Company Market Share, 2021
8.5.1 Competitive Dashboard Analysis
8.6 Private Companies
8.6.1 List of Key Emerging Companies
8.6.2 Regional Network Map
8.7 Company Profiles
8.7.1 Bayer AG
8.7.1.1 Company overview
8.7.1.2 Financial performance
8.7.1.3 Product benchmarking
8.7.1.4 Strategic initiatives
8.7.2 Cipla, Inc.
8.7.2.1 Company overview
8.7.2.2 Financial performance
8.7.2.3 Product benchmarking
8.7.2.4 Strategic initiatives
8.7.3 GSK Group of Companies
8.7.3.1 Company overview
8.7.3.2 Financial performance
8.7.3.3 Product benchmarking
8.7.3.4 Strategic initiatives
8.7.4 Johnson & Johnson Private Limited
8.7.4.1 Company overview
8.7.4.2 Financial performance
8.7.4.3 Product benchmarking
8.7.4.4 Strategic initiatives
8.7.5 Novartis AG
8.7.5.1 Company overview
8.7.5.2 Financial performance
8.7.5.3 Product benchmarking
8.7.5.4 Strategic initiatives
8.7.6 Bausch Health Companies Inc.
8.7.6.1 Company overview
8.7.6.2 Product benchmarking
8.7.6.3 Strategic initiatives
8.7.7 Hisamitsu Pharmaceuticals Co. Inc.
8.7.7.1 Company overview
8.7.7.2 Financial performance
8.7.7.3 Product benchmarking
8.7.8 Merck & Co. Inc.
8.7.8.1 Company overview
8.7.8.2 Financial performance
8.7.8.3 Product benchmarking
8.7.8.4 Strategic initiatives
8.7.9 Glenmark Pharmaceuticals Ltd.
8.7.9.1 Company overview
8.7.9.2 Financial performance
8.7.9.3 Product benchmarking
8.7.9.4 Strategic initiatives
8.7.10 MedPharm Ltd.
8.7.10.1 Company overview
8.7.10.2 Financial performance
8.7.10.3 Product benchmarking
8.7.10.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Topical Drugs Market, By Region, 2018-2030 (USD Million)
Table 4 Global Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 5 Global Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 6 Global Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 7 North America Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 8 North America Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 9 North America Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 10 U.S. Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 11 U.S. Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 12 U.S. Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 13 Canada Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 14 Canada Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 15 Canada Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 16 Europe Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 17 Europe Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 18 Europe Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 19 Germany Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 20 Germany Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 21 Germany Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 22 U.K. Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 23 U.K. Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 24 U.K. Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 25 France Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 26 France Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 27 France Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 28 Italy Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 29 Italy Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 30 Italy Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 31 Spain Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 32 Spain Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 33 Spain Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 34 Russia Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 35 Russia Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 36 Russia Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 37 Asia Pacific Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 38 Asia Pacific Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 39 Asia Pacific Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 40 Japan Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 41 Japan Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 42 Japan Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 43 China Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 44 China Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 45 China Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 46 India Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 47 India Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 48 India Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 49 South Korea Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 50 South Korea Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 51 South Korea Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 52 Australia Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 53 Australia Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 54 Australia Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 55 Latin America Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 56 Latin America Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 57 Latin America Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 58 Brazil Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 59 Brazil Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 60 Brazil Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 61 Mexico Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 62 Mexico Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 63 Mexico Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 64 Argentina Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 65 Argentina Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 66 Argentina Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 67 Middle East & Africa Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 68 Middle East & Africa Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 69 Middle East & Africa Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 70 Saudi Arabia Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 71 Saudi Arabia Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 72 Saudi Arabia Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 73 South Africa Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 74 South Africa Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 75 South Africa Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
Table 76 UAE Topical Drugs Market, By Type, 2018-2030 (USD Million)
Table 77 UAE Topical Drugs Market, By Route of Administration, 2018-2030 (USD Million)
Table 78 UAE Topical Drugs Market, By End-Use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Topical Drugs market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Topical Drugs market snapshot
FIG. 10 Parent market outlook
FIG. 11 Related/ancillary market outlook, revenue, 2021, (USD Million)
FIG. 12 Penetration and growth prospect mapping
FIG. 13 Topical drugs market driver impact
FIG. 14 Topical drugs market restraint impact
FIG. 15 SWOT analysis, by factor (political & legal, economic, and technological)
FIG. 16 Industry Analysis-Porter’s
FIG. 17 Strategy mapping
FIG. 18 Topical drugs market: Type outlook and key takeaways
FIG. 19 Topical drugs market: Type movement analysis & market share 2021 & 2030
FIG. 20 Semi-solid formulations market estimates and forecast, 2018-2030 (USD Million)
FIG. 21 Creams market estimates and forecast, 2018-2030 (USD Million)
FIG. 22 Ointments market estimates and forecast, 2018-2030 (USD Million)
FIG. 23 Lotions market estimates and forecast, 2018-2030 (USD Million)
FIG. 24 Gel market estimates and forecast, 2018-2030 (USD Million)
FIG. 25 Pastes market estimates and forecast, 2018-2030 (USD Million)
FIG. 26 Liquid formulations market estimates and forecast, 2018-2030 (USD Million)
FIG. 27 Suspensions market estimates and forecast, 2018-2030 (USD Million)
FIG. 28 Solutions market estimates and forecast, 2018-2030 (USD Million)
FIG. 29 Solid formulations market estimates and forecast, 2018-2030 (USD Million)
FIG. 30 Powders market estimates and forecast, 2018-2030 (USD Million)
FIG. 31 Suppositories market estimates and forecast, 2018-2030 (USD Million)
FIG. 32 Transdermal products market estimates and forecast, 2018-2030 (USD Million)
FIG. 33 Transdermal patches market estimates and forecast, 2018-2030 (USD Million)
FIG. 34 Transdermal semi-solids market estimates and forecast, 2018-2030 (USD Million)
FIG. 35 Topical drugs market: Route of Administration outlook and key takeaways
FIG. 36 Topical drugs market: Route of Administration movement analysis & market share 2021 & 2030
FIG. 37 Dermal drug delivery market estimates and forecast, 2018-2030 (USD Million)
FIG. 38 Ophthalmic drug delivery market estimates and forecast, 2018-2030 (USD Million)
FIG. 39 Rectal drug delivery market estimates and forecast, 2018-2030 (USD Million)
FIG. 40 Vaginal market estimates and forecast, 2018-2030 (USD Million)
FIG. 41 Nasal market estimates and forecast, 2018-2030 (USD Million)
FIG. 42 Topical drugs market: End-Use outlook and key takeaways
FIG. 43 Topical drugs market: End-Use movement analysis & market share 2021 & 2030
FIG. 44 Home care settings market estimates and forecast, 2018-2030 (USD Million)
FIG. 45 Hospitals & clinics market estimates and forecast, 2018-2030 (USD Million)
FIG. 46 Burn centres market estimates and forecast, 2018-2030 (USD Million)
FIG. 47 Other facilities market estimates and forecast, 2018-2030 (USD Million)
FIG. 48 Topical drugs: Regional outlook and key takeaways
FIG. 49 Regional outlook, 2021 & 2030
FIG. 50 North America
FIG. 51 North America market estimates and forecast, 2018-2030 (USD Million)
FIG. 52 U.S.
FIG. 53 U.S. market estimates and forecast, 2018-2030 (USD Million)
FIG. 54 Canada
FIG. 55 Canada market estimates and forecast, 2018-2030 (USD Million)
FIG. 56 Europe
FIG. 57 Europe market estimates and forecast, 2018-2030 (USD Million)
FIG. 58 U.K.
FIG. 59 U.K. market estimates and forecast, 2018-2030 (USD Million)
FIG. 60 Germany
FIG. 61 Germany market estimates and forecast, 2018-2030 (USD Million)
FIG. 62 France
FIG. 63 France market estimates and forecast, 2018-2030 (USD Million)
FIG. 64 Italy
FIG. 65 Italy market estimates and forecast, 2018-2030 (USD Million)
FIG. 66 Spain
FIG. 67 Spain market estimates and forecast, 2018-2030 (USD Million)
FIG. 68 Russia
FIG. 69 Russia market estimates and forecast, 2018-2030 (USD Million)
FIG. 70 Asia-Pacific
FIG. 71 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
FIG. 72 Japan
FIG. 73 Japan market estimates and forecast, 2018-2030(USD Million)
FIG. 74 China
FIG. 75 China market estimates and forecast, 2018-2030 (USD Million)
FIG. 76 India
FIG. 77 India market estimates and forecast, 2018-2030 (USD Million)
FIG. 78 South Korea
FIG. 79 South Korea market estimates and forecast, 2018-2030 (USD Million)
FIG. 80 Australia
FIG. 81 Australia market estimates and forecast, 2018-2030 (USD Million)
FIG. 82 Singapore
FIG. 83 Singapore market estimates and forecast, 2018-2030 (USD Million)
FIG. 84 Latin America
FIG. 85 Latin America market estimates and forecast, 2018-2030 (USD Million)
FIG. 86 Brazil
FIG. 87 Brazil market estimates and forecast, 2018-2030 (USD Million)
FIG. 88 Mexico
FIG. 89 Mexico market estimates and forecast, 2018-2030 (USD Million)
FIG. 90 Argentina
FIG. 91 Argentina market estimates and forecast, 2018-2030 (USD Million)
FIG. 92 Middle East & Africa
FIG. 93 MEA market estimates and forecast, 2018-2030 (USD Million)
FIG. 94 South Africa
FIG. 95 South Africa market estimates and forecast, 2018-2030 (USD Million)
FIG. 96 Saudi Arabia
FIG. 97 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
FIG. 98 UAE
FIG. 99 UAE market estimates and forecast, 2018-2030 (USD Million)
FIG. 100 Market differentiators
FIG. 101 Key company market share analysis, 2021
FIG. 102 Company market position analysis
FIG. 103 Competitive dashboard analysis
FIG. 104 Regional network map

Companies Mentioned

  • Bayer AG
  • Cipla, Inc.
  • GSK Group of Companies
  • Johnson & Johnson Private Limited
  • Novartis AG
  • Bausch Health Companies Inc.
  • Hisamitsu Pharmaceuticals Co. Inc.
  • Merck & Co. Inc.
  • Glenmark Pharmaceuticals Ltd.
  • MedPharm Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJuly 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 100.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 217.79 Billion
Compound Annual Growth Rate10.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Topical Drug Delivery Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), Rout to Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery), End-User - Forecast 2024-2030 - Product Image

Global Topical Drug Delivery Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), Rout to Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery), End-User - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Topical Drugs Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), End-use (Burn Centers, Home Care Settings, Hospitals & Clinics) - Forecast 2024-2030 - Product Image

Global Topical Drugs Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), End-use (Burn Centers, Home Care Settings, Hospitals & Clinics) - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Topical Drug Delivery Global Market Report 2024 - Product Image

Topical Drug Delivery Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Topical Drug Delivery - Global Strategic Business Report - Product Image

Topical Drug Delivery - Global Strategic Business Report

  • Report
  • 94 Pages
  • Global
From
Global Topical Drug Delivery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Topical Drug Delivery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 172 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.